Glioblastoma

Study details novel method to create personalized mRNA-based vaccines to target brain tumors.

Dr. Jianping Huang and colleagues publish paper in the journal Acta Biomaterialia.

Fifth annual ReMission Summit brought together top brain tumor researchers and clinicians to advance new treatments.

Videos aired during The V Foundation's "V Week" highlight UF Health’s efforts to fight brain cancer.

Research spotlight focuses on Dr. Duane Mitchell, winner of the 2022 Clinical Science Research Award.

UF researchers provide new insight into the makeup of glioblastoma cells and potential targets for interventions.

New research shows Tumor Treating Fields could stimulate an immune system response against recurrent glioblastoma.

A new study led by Loic Deleyrolle, Ph.D., an assistant professor of neurosurgery, has implications for advancing new metabolic therapies for glioblastoma, the deadliest form of brain cancer.

On Saturday, Aug. 25, Sen. John McCain lost his courageous year-plus battle with glioblastoma. Dr. Duane Mitchell discusses the disease and his hope for future research breakthroughs.

Brain tumors, which are abnormal growths of cells within the brain, can be cancerous (malignant) and spread if not properly treated. More than 200,000 people in the U.S. receive the diagnosis of primary or metastatic brain tumor every year and, unfortunately, this number has been increasing. Gliomas, which represent a…